Summary
Introduction
The measurement of plasma catecholamines is frequently used as an index of sympathetic nervous activity [l, 21. However, more than a decade has passed since the advent of a specific radioenzymatic method for their assay without the ready availability of a simple and reproducible method [3]. The sensitivity of the catechol 0-methyltransferase-based assay depends on both (a) obtaining a high-activity preparation of enzyme and (b) the use of S-[3H]adenosyl-~-methionine as the methylgroup donor [4-91. The present modification suggests a simple method of increasing the purity of catechol 0-methyltransferase without a reduction in yield and describes how S-[3Hladenosyl-L-methionine can be retained in association with a l4C-labe1led tracer to improve precision. This requirement for a tracer was met in the earlier S-[ I4C 1-adenosyl-L-methionine-dependent catechol 0-methyltransferase assays 10, 111. It follows from the need to use saturating concentrations of S-adenosyl-L-methionine and the multiple stages consequently required after the incubation to separate the product from the great excess of S-adenosyl-L-methionine. the solvent front and origin respectively) marked mmol) were from The Radiochemical Centre, Amersham Bucks., U.K. The former was delivered monthly and stored, in suitable portions, over liquid nitrogen. Tetraphenylboron sodium was purchased from Aldrich Chemical Co, and all solvents were from BDH. All other chemicals were purchased from Sigma Chemical c o .
Materials and methods

S-[3H]Adenosyl-~-methionine (60-85
Enzyme preparation
Catechol 0-methyltransferase was prepared from rat livers as described by Axelrod & Tomchick [121, and the final preparation freezedried and stored at -8OOC. Before removal of their livers, the rats were pretreated as follows. Two days before killing, 6-hydroxydopamine (100 mg/kg) was injected intraperitoneally. On the day of the enzyme preparation, the rats were anaesthetized with intraperitoneal pentobarbitone (50 mg/kg) and the adrenal glands excised through a laparotomy incision. One hour later, NaCl solution (0.9%, 150 mmol/l: saline) (previously warmed to 37°C) was infused into the hepatic portal vein through a 19-gauge butterfly needle, until the liver was exsanguinated (2-3 min). The liver was then removed. Through the various steps of its purification care was taken to maintain the enzyme preparation at 4°C.
Sample collection and preparation
Blood (0.5-1 ml) was collected into chilled lithium-heparin tubes and the plasma separated within 30 min in a refrigerated centrifuge. Haemolysed samples were discarded. Plasma samples were stored at -8OOC until assay. They were then thawed, mixed and centrifuged for 10 min at 4OC. Portions (50 pl) from each sample were pipetted, in triplicate, into polypropylene tubes. Each assay also included: (a) four to six blanks, consisting of either distilled water or plasma previously incubated at 4OC with 0.04% sodium metaperiodate; (b) four to six standards, consisting of plasma + 0.5 ng each of noradrenaline and adrenaline dissolved in 5 pl of HCI (0.01 mol/l); (c) two 'pooled plasma' samples. All tubes were kept on ice until addition of the incubation mixture.
Preparation of incubation mixture
Two of these were prepared. Initially, catechol 0-methyltransferase (3 mg/ml of the final mixture) and reduced glutathione (2 mg/ml) were dissolved in a buffer of Tris (800 mmol/l), magnesium chloride (240 mmol/l) and ethylthis buffer has the desired optimum pH for catechol 0-methyltransferase activity of 8.4 and is stored, in bulk, at 4OC. A 10 pl portion of a 0.5% solution of benzylhydroxylamine was added per millilitre of this mixture. This was then divided into two parts: to one was added 300 pCi of S-[3Hladenosyl-~-methionine/ml and to the other 300 nCi of S-[ 14C]adenosyl-~-methionine /ml and 300 ng 'each of noradrenaline and adrenaline/ml. A 25 p1 portion of the 3H-labelled mixture was added to two tubes of each triplicate and to the third was added 25 pl of the 14C-labelled mixture. All tubes were briefly vortexed before being placed for 90 min in a shaking water bath, at 25OC.
Termination of reaction and extraction of methylated amines
At the end of the incubation, the tubes were placed on ice. A 20 p1 portion of borate (1 mol/l, pH 8.0), containing 0.1% unlabelled S-adenosyl-L-methionine, was pipetted into the I4C tubes only; these were briefly vortexed. A 40 pl portion from each 14C tube was then carefully transferred to each of the 3H tubes of the triplicate, after which the 14C tube was discarded. The remaining tubes (now containing both 3H-and ''C-labelled metadrenalines) then received 50 p1 of a mixture comprising tetraphenylboron sodium (5 mg/ml), as described previously [6] , and 10 pglml each of unlabelled metadrenaline and normetadrenaline dissolved in borate (1 mol/l, pH 8.0). Diethyl ether (2 ml) was dispensed into the tubes, which were then vortexed for 30 s. After phase separation by centifugation, the aqueous layer was frozen in solid carbon dioxide/acetone and the ether phase of each tube decanted into a glass tube containing 25 pl of HCI (0.1 mol/l) + 0.1% unlabelled metadrenalines. These tubes were vortexed for 30 s and the phases separated as before. On this occasion the ether layer was discarded and residual ether blown off in a vortex evaporator.
Thin-layer chromatography (t.1.c.)
The 25 pl aqueous layers were spotted, in one application, on the pre-adsorbent origins of pre-channelled Whatman silica-gel plates containing a fluorescent indicator. The plates were blown dry (15-20 min) and developed in chloroform/ methanol/70% ethylamine (32 : 6 :4, by vol.) as described previously 161. After 40-45 min, they were removed, blown dry and the two bands (metadrenaline and normetadrenaline were nearer under ultraviolet (u.v.) light. A drop of water was applied to each spot, facilitating rapid scraping into a tube containing 1 ml of aq. ammonia solution (0.05 mol/l). prior treatment of rats described here) and (b) enzyme purified by gel-filtration (purchased from Sigma Chemical Co.).
The precision of the assay was determined by
Oxidation and final extraction
The tubes were shaken for 5 min before 75 pl of a fresh 4% (w/v) sodium metaperiodate solution was added. After 10 min, 25 p1 of acetic acid was added, followed by 10 ml of toluene. The tubes were stoppered and the two phases mixed by shaking for 10 min. They were then briefly centrifuged at 1000 g and the aqueous layer was frozen as before. Finally the toluene was decanted into scintillation vials containing 0.4 ml of Permafluor (Packard). These were counted for radioactivity in a Packard scintillation counter and the 3H/14C ratio for each sample was determined. The catecholamine content was then determined by comparing this ratio to that of the samples to which known amounts of catecholamine standards were added (to the 3H as well as 14C tubes) before the initial incubation.
The linearity and sensitivity of the assay were determined by assaying plasma blanks, after reduction of the periodate by excess (0.1%) glutathione, with increasing concentrations of catecholamine standards. Plasma blanks were compared also with water blanks. Values for blanks and standards were compared with those obtained by using (a) 'conventionally' prepared catechol 0-methyltransferase (that is, without the 1 0 0 5 0 assaying several portions of a pooled plasma sample (mean concentration of noradrenaline and adrenaline respectively 1 a 2 and 0.2 nmol/l) both on the same and different occasions, up to 6 months apart. For comparison, other portions of the same sample were assayed by catechol 0-methyltransferase assay described previously [61; also their noradrenaline concentration alone was measured by the phenylethanolamine Nmethyltransferase-based radioenzymatic assay [131.
The specificity was checked by assaying plasma samples with and without addition of possible interfering compounds (100 ng/ml).
Results
The assay was linear for both catecholamines between 0 and lo5 pg/ml (Fig. 1) . The sensitivity, defined as the lowest concentration distinguishable with 95% confidence from background, was 1 -5 pg/ml (10 pmol/l) for both noradrenaline and varied among plasmas; however, the 3H/14C ratio for 1 ng was the same in all plasmas, and for 10 pg/ml (0.058 nmol/l) was twice the blank. So sensitivity was not reduced in plasma samples which strongly inhibited catechol O-methyltransferase activity, since the recovery of 14C d.p.m. was reduced by the same proportion as that of 3H d.p.m. Table 1 compares these values for blanks and standards with those obtained with either 'conventionally' prepared or commercially purified catechol 0-methyltransferase. The intra-assay coefficients of variation were 3.0 and 3.2% respectively for noradrenaline and adrenaline; the inter-assay coefficients were 4.6 and 5.0%. Table 2 illustrates how the use of the 3H/14C ratio gives better precision than use of the tritium counts alone. The precision of this assay is compared with that of other radioenzymatic assays in Table 3 .
The assay was highly specific for noradrenaline and adrenaline (Table 4) , with no endogenous amines interfering at physiological concentrations. However, adrenaline could not be reliably assayed in patients receiving methyldopa therapy, in whom circulating cr-methylnoradrenaline may be present [6,7, 141; use of the aromatic amino acid decarboxylase inhibitor, benzylhydroxylamine, was necessary to prevent dopamine formation from the relatively high, concentrations of endogenous plasma DOPA,
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leading to interference with adrenaline measurements [7, 151. Dithiothreitol was found unsuitable as an anti-oxidant in the incubation mixture, since impurities tend to cause high adrenaline blanks: this probably results from the cyclization of dithiothreitol, on oxidation, to a catechol-like structure which may then be methylated in the presence of catechol 0-methyltransferase [ 
161.
Discussion
Many modifications of the original catechol 0-methyltransferase assay have been described; the present assay is largely based on two of these which incorporate t.1.c. stages [6, 71. However, initial problems in this laboratory with high blanks, low sensitivity and low precision were not resolved by close adherence to any published modifications and led to a systematic attempt to identify and solve the problems.
After the demonstration that laboratory rats tend to have grossly elevated levels of circulating catecholamines if subjected to any form of manipulation or restraint, it was suspected that high backgrounds in the assay might be due to endogenous catecholamines being accumulated in the rat liver immediately before death 117, 181. Similar suspicions have been expressed.by others [31, although attempts to confirm the presence of catecholamine contaminants by their selective adsorbance to alumina at pH 8.3-8.6 are thwarted by the inhibition of catechol O-methyltransferase activity by aluminium ions [191. The potential increase in sensitivity offered by the recent availability of high specific radioactivity S-[3Hladen~syl-~-methionine (60-85 Ci/mmol) increased the need to remove any endogenous catecholamines contaminating the enzyme; for an increased specific radioactivity would not increase the sample to blank signal unless the latter was largely constant, and comprised mainly the background inherent in the scintillation counter. The ablation in viuo of sympathoadrenal tissue proved preferable to further steps in the enzyme purification, which lowered both the yield and stability of the final enzyme preparation. The pretreatment of the rats was found also slightly to increase the apparent maximal activity of the enzyme (Table 1) ; this could be due to removal either of catechol and other substrates for methyltransferases which complete for the S-adenosyl-L-methionine, or possibly of unlabelled S-adenosyl-L-methionine itself, which otherwise dilutes the label.
When unextracted plasma samples were used in the incubation it was found that the efficiency of methylation at 25OC was up to two-fold that at 37°C. This may be because efficiency of methylation depends on substrate (catecholamine and S-adenosyl-L-methionine) stability at pH 8-4, as well as on the balance between enzyme activity and stability. The optimum temperature is apparently lower than for assays of the enzyme's activity, performed with excess substrate, in which only the latter balance is of importance. This may be a general feature of S-adenosyl-L-methionine-dependent radioenzymatic assays, having been described also for the assay of plasma histamine 1201.
The application of a double-isotope method is the major innovation of the assay. It is clearly difficult to assure an equal recovery for the duplicate portions of a sample when at least 10 steps are involved in the extraction and separation of the methylated amines after the incubation, from which the final recovery is little higher than 40% [61. Most of the early catechol 0-methyltransferase assays used a double-isotope method, but suffered from the low sensitivity that could be achieved with the specific radioactivity of a [14C]methyl donor. The introduction of S-[ 3H I adenosyl-L-methionine permitted a great increase in sensitivity, but led to single-isotope assays; their requirement for more separation procedures after the incubation, especially t.l.c., to maintain low blanks in fact increases the need for a correction factor. It is not possible to add tracer [14C]catecholamine to each sample before the incubation, since the amount of tracer catecholamine necessary to yield measurable levels of counts would be much higher than the unknown amount of catecholamine being assayed; hence most of the 3H counts would be derived from methylation of the tracer. However, if [ ''Clmetadrenalines are added after the methylation reaction is stopped, they provide a tracer to correct for recovery through the extraction stages of the assay, without contributing to the formation of [3Hlmetadrenalines.
(There is, of course, a physical cross-over of 14C counts into the 3H channel of the scintillation counter, which can be corrected for, and causes no loss of sensitivity when the 14C counts are of the same order as, or lower than, the 3H counts.) The addition of excess non-radioactive Sadenosyl-L-methionine at the end of the incubation ensures that any further methylation of the catecholamine standards when added to the 3H tubes will not yield ['Hlmetadrenalines.
A similar principle was used in an earlier modification, in which [14C]metadrenalines were formed enzymatically on a separate occasion, and a fixed amount was added to each sample after the incubation; unfortunately, the two-dimensional t.1.c. required in that modification led to such low recoveries that the sensitivity was too low to permit measurement of normal plasma adrenaline levels in man [211. In the present modification enzymatic formation of the [14C]-metadrenalines in the presence of each plasma sample provides a correction for inter-plasma variation in the efficiency of methylation. Plasma is well recognized as inhibiting methyltransferase activity, though the factors responsible are less certain [71. Deproteination alone without dilution is not very effective at removing inhibition. It is possible that competition for the S-adenosyl-L-methionine by non-specific methyltransferases in the enzyme preparation is a factor, since increasing the concentration of S-adenosyl-Lmethionine in the incubation mixture above that required for optimal catechol O-methyltransferase activity (in buffer) was found to decrease the inhibition. Both the volume and cost of the S-[3H]adenosyl-~-methionine limit the extent to which its concentration can be increased in practice; it is important, however, that in the assay described here equimolar concentrations of S-adenosyl-L-methionine are present in the 3H and I4C mixtures, to ensure that the efficiency of methylation is the same in both sets of tubes.
So the recovery, at the end of the assay, of [ l4C]metadrenalines corrects both for methylation and for extraction losses, as if [14Clcatechol-amine tracer had been added to the samples at the start of the assay, but without the loss of sensitivity this would entail. For a given plasma sample, the degree of methylation is constant, hence the use of only one 14C-labelled portion for each sample. This is justified by the low intraassay coefficient of variation. Because, after the incubation, only two tubes are necessary for each sample (none being required for internal standards), the assay is capable of handling relatively large numbers of samples. Two people can assay 30-35 samples for both noradrenaline and adrenaline, or 45-50 samples for one catecholamine alone in an 8 h day. This large capacity is partly also due to the use of t.1.c. plates which permit the application of 25-50 pl of sample and thus eliminate the need for sample reduction at this stage. This increase in sample capacity does little, however, to lower the cost of the assay which is due mainly to the need for saturating concentrations of the label (S-adenosyl-Lmethionine).
Although the assay is mainly used, as described here, for the measurement of noradrenaline and adrenaline, it is applicable to the assay of any catecholamine whose 0-methyl derivative is separable by t.1.c. from the metadrenalines. Only P-hydroxylated catecholamines, however, can undergo the final periodate oxidation. The same double-isotope modification could also be used in other radioenzymatic assays in which unextracted plasma is incubated with enzyme and S-adenosyl-L-methionine. It could not, however, be used to improve the precision of the phenylethanolamine N-methyltransferase assay of noradrenaline, which includes an alumina extraction before the incubation [131. 
